Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, E. S.
Right arrow Articles by Hylton, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, E. S.
Right arrow Articles by Hylton, N. M.
Related Collections
Right arrow Diagnosis
Annals of Surgical Oncology 10:381-388 (2003)
© 2003 Society of Surgical Oncology


ORIGINAL ARTICLES

Magnetic Resonance Imaging in Patients Diagnosed With Ductal Carcinoma-In-Situ: Value in the Diagnosis of Residual Disease, Occult Invasion, and Multicentricity

E. Shelley Hwang, MD, Karen Kinkel, MD, Laura J. Esserman, MD, Ying Lu, PhD, Noel Weidner, MD and Nola M. Hylton, PhD

From the Departments of Surgery (ESH, LJE), Pathology (NW), and Radiology (KK, YL, NMH), University of California–San Francisco, San Francisco, California.

Correspondence: Address correspondence and reprint requests to: E. Shelley Hwang, MD, UCSF Department of Surgery, 1600 Divisadero Street, Room B611, San Francisco, CA 94115; Fax: 415-353-9571; E-mail: shelley.hwang{at}ucsfmedctr.org

Background: Although magnetic resonance imaging (MRI) has been shown to be a sensitive imaging tool for invasive breast cancers, its utility in ductal carcinoma-in-situ (DCIS) of the breast remains controversial. We studied the performance of MRI in patients with known DCIS for assessment of residual disease, occult invasion, and multicentricity to determine the clinical role of MRI in this setting.

Methods: Fifty-one patients with biopsy-proven DCIS underwent contrast-enhanced MRI before surgical treatment. Pre-, early post-, and late postcontrast three-dimensional gradient echo images were obtained and MRI findings were correlated with histopathology. When possible, the performance of MRI and mammography was compared.

Results: The accuracy of MRI was 88% in predicting residual disease, 82% in predicting invasive disease, and 90% in predicting multicentricity. The performance of MRI was equivalent in the core biopsy group when compared with the surgical biopsy group. For occult invasion only, MRI and mammography were equivalent. However, overall, MRI was more sensitive and had a higher negative predictive value than mammography.

Conclusions: MRI of DCIS can serve as a useful adjunct to mammography by providing a more accurate assessment of the extent of residual or multicentric disease. The performance of MRI is not significantly affected by antecedent surgical excision. MRI may be particularly valuable if preoperatively negative.

Key Words: Breast cancer • Ductal carcinoma-in-situ • Magnetic resonance imaging • Comparative studies • Mammography




This article has been cited by other articles:


Home page
RadiologyHome page
N. H. G. M. Peters, I. H. M. Borel Rinkes, N. P. A. Zuithoff, W. P. T. M. Mali, K. G. M. Moons, and P. H. M. Peeters
Meta-Analysis of MR Imaging in the Diagnosis of Breast Lesions
Radiology, December 1, 2007; 246(1): 116 - 124.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. K. Kuhl
Current Status of Breast MR Imaging * Part 2. Clinical Applications
Radiology, September 1, 2007; 244(3): 672 - 691.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. Kuhl
The Current Status of Breast MR Imaging * Part I. Choice of Technique, Image Interpretation, Diagnostic Accuracy, and Transfer to Clinical Practice
Radiology, August 1, 2007; 244(2): 356 - 378.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. J. Esserman, A. S. Kumar, A. F. Herrera, J. Leung, A. Au, Y.-Y. Chen, D. H. Moore, D. F. Chen, J. Hellawell, D. Wolverton, et al.
Magnetic Resonance Imaging Captures the Biology of Ductal Carcinoma In Situ
J. Clin. Oncol., October 1, 2006; 24(28): 4603 - 4610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. D. Lehman, S. Peacock, W. B. DeMartini, and X. Chen
A new automated software system to evaluate breast MR examinations: improved specificity without decreased sensitivity.
Am. J. Roentgenol., July 1, 2006; 187(1): 51 - 56.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
S. K. Shah, S. K. Shah, and K. V. Greatrex
Current Role of Magnetic Resonance Imaging in Breast Imaging: A Primer for the Primary Care Physician
J Am Board Fam Med, November 1, 2005; 18(6): 478 - 490.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. K. Kuhl, H. H. Schild, and N. Morakkabati
Dynamic Bilateral Contrast-enhanced MR Imaging of the Breast: Trade-off between Spatial and Temporal Resolution
Radiology, September 1, 2005; 236(3): 789 - 800.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. Hylton
Magnetic Resonance Imaging of the Breast: Opportunities to Improve Breast Cancer Management
J. Clin. Oncol., March 10, 2005; 23(8): 1678 - 1684.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. D. Leonard and S. M. Swain
Ductal Carcinoma In Situ, Complexities and Challenges
J Natl Cancer Inst, June 16, 2004; 96(12): 906 - 920.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
F. H. Bagley
The Role of Magnetic Resonance Imaging Mammography in the Surgical Management of the Index Breast Cancer
Arch Surg, April 1, 2004; 139(4): 380 - 383.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society of Surgical Oncology.